The Development Department at BTG is an integral part of the Ferring Global Pharmaceutical R&D organization
- Develops cGMP manufacturing processes and analytical methodology for both bacterially-derived and mammalian cell culture-based recombinant proteins undergoing pre-clinical and clinical studies
- Supports existing Ferring products manufactured by BTG
- Performs CMC activities related to biotechnology-based APIs
- Has experience and expertise in biopharmaceutical regulatory affairs
The Development organization successfully integrates all the elements needed to develop quality biopharmaceuticals, and its location within BTG ensures efficient technology transfer to Manufacturing and affords access to considerable production know-how and expertise.
The BTG Regulatory Affairs Department is responsible for providing regulatory support to BTG commercial products and Ferring global recombinant products under development.